Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all

Anyone on Topiramate?

27 Posts
27 Users
0 Reactions
1,304 Views
maple8413
(@maple8413)
New Member
Joined: 6 years ago
Posts: 1
 

Narrow conclusion.



   
ReplyQuote
atlasjar37
(@atlasjar37)
New Member
Joined: 2 years ago
Posts: 2
 

Baseline first. Without a baseline the after picture is decoration. Lethargy in the first fortnight was my main issue with CJC-1295 too.



   
ReplyQuote
wrentide62
(@wrentide62)
Active Member
Joined: 6 months ago
Posts: 9
 

Narrow conclusion. How long have you been on CJC-1295?



   
ReplyQuote
rowankey50
(@rowankey50)
New Member
Joined: 1 year ago
Posts: 4
 

Narrow conclusion.



   
ReplyQuote
chipgale
(@chipgale)
Active Member
Joined: 5 months ago
Posts: 5
 

Same here.

Same for me with CJC-1295, unfortunately.



   
ReplyQuote
wren_cloud
(@wren_cloud)
Active Member
Joined: 6 years ago
Posts: 6
 

Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.



   
ReplyQuote
shorestar
(@shorestar)
Active Member
Joined: 5 years ago
Posts: 5
 

Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.



   
ReplyQuote
quillcrown54
(@quillcrown54)
Active Member
Joined: 4 months ago
Posts: 7
 

An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.



   
ReplyQuote
MoorKiln
(@moorkiln)
Active Member
Joined: 1 year ago
Posts: 6
 

Narrow conclusion. How long have you been on CJC-1295?



   
ReplyQuote
tidehead54
(@tidehead54)
Active Member
Joined: 4 years ago
Posts: 5
 

Same here.

Currently on CJC-1295 myself.



   
ReplyQuote
flint2068
(@flint2068)
Active Member
Joined: 1 year ago
Posts: 8
 

Read methods. Currently on CJC-1295 myself.



   
ReplyQuote
umber4282
(@umber4282)
Active Member
Joined: 3 years ago
Posts: 7
 

Sleep, food, or the compound? Yes.



   
ReplyQuote
Page 2 / 2
Share: